Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

INTERVIEW: MHRA chief Ian Hudson on the hot topics in pharma, Part 1

This article was originally published in SRA

Executive Summary

When Scrip Regulatory Affairs editor Maureen Kenny interviewed Ian Hudson, the chief executive of the UK Medicines and Healthcare Products Regulatory Agency had just got back from an official trip to India. We asked Dr Hudson how the trip had gone and questioned him about a host of other pharmaceutical-related regulatory topics including international initiatives to promote co-operation on inspections; changing faces among the heads of EU medicines agencies; evolving workload patterns at the MHRA, the new EU Clinical Trials Regulation, the agency's activities in the area of Ebola… and the possibility that the UK might ultimately leave the EU.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS118001

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel